[go: up one dir, main page]

DE69926996D1 - Verwendung von riluzol zur behandlung der retinalischemie - Google Patents

Verwendung von riluzol zur behandlung der retinalischemie

Info

Publication number
DE69926996D1
DE69926996D1 DE69926996T DE69926996T DE69926996D1 DE 69926996 D1 DE69926996 D1 DE 69926996D1 DE 69926996 T DE69926996 T DE 69926996T DE 69926996 T DE69926996 T DE 69926996T DE 69926996 D1 DE69926996 D1 DE 69926996D1
Authority
DE
Germany
Prior art keywords
riluzol
retinal
mixture
treatment
retinal mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69926996T
Other languages
English (en)
Other versions
DE69926996T2 (de
Inventor
Michel Lazdunski
Catherine Heurteaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE69926996D1 publication Critical patent/DE69926996D1/de
Application granted granted Critical
Publication of DE69926996T2 publication Critical patent/DE69926996T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69926996T 1998-02-17 1999-02-16 Verwendung von riluzol zur behandlung der retinalischemie Expired - Lifetime DE69926996T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9801915 1998-02-17
FR9801915A FR2774908B1 (fr) 1998-02-17 1998-02-17 Utilisation d'inhibiteur de la liberation du glutamate dans le traitement de l'ischemie retinienne
PCT/FR1999/000350 WO1999042103A1 (fr) 1998-02-17 1999-02-16 Utilisation d'inhibiteur de la liberation du glutamate dans le traitement de l'ischemie retinienne

Publications (2)

Publication Number Publication Date
DE69926996D1 true DE69926996D1 (de) 2005-10-06
DE69926996T2 DE69926996T2 (de) 2006-06-29

Family

ID=9523066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69926996T Expired - Lifetime DE69926996T2 (de) 1998-02-17 1999-02-16 Verwendung von riluzol zur behandlung der retinalischemie

Country Status (5)

Country Link
EP (1) EP1054668B1 (de)
DE (1) DE69926996T2 (de)
ES (1) ES2247779T3 (de)
FR (1) FR2774908B1 (de)
WO (1) WO1999042103A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL365378A1 (en) * 2000-11-30 2005-01-10 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
FR2852245B1 (fr) * 2003-03-11 2006-08-11 Utilisation du diazoxide dans le traitement de l'ischemie retinienne
EP1477166B1 (de) * 2003-04-28 2006-08-23 Biofrontera Bioscience GmbH Verwendung von Riluzole kombiniert mit geeigneten Hilfs-und Zusatzstoffen zur Behandlung von Krankheiten, die durch eine Hyperproliferation von Keratinozyten gekennzeichnet sind, insbesondere Neurodermitis und Psoriasis
KR20050036195A (ko) * 2003-10-15 2005-04-20 고재영 신규한 망막병증 치료제 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.

Also Published As

Publication number Publication date
ES2247779T3 (es) 2006-03-01
FR2774908A1 (fr) 1999-08-20
EP1054668B1 (de) 2005-08-31
FR2774908B1 (fr) 2000-06-23
EP1054668A1 (de) 2000-11-29
WO1999042103A1 (fr) 1999-08-26
DE69926996T2 (de) 2006-06-29

Similar Documents

Publication Publication Date Title
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69836915D1 (de) Mundpflegemittel zur behandlung von übelriechendem atem
ATE527022T1 (de) Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition